FWG Holdings LLC bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 2nd quarter, Holdings Channel reports. The fund bought 2,037 shares of the technology company’s stock, valued at approximately $581,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Abound Financial LLC purchased a new position in shares of Veeva Systems in the 1st quarter valued at approximately $25,000. Trust Co. of Toledo NA OH acquired a new stake in shares of Veeva Systems during the second quarter worth $29,000. Wayfinding Financial LLC purchased a new position in Veeva Systems in the 1st quarter valued at $32,000. Legacy Investment Solutions LLC acquired a new position in Veeva Systems in the 2nd quarter valued at $32,000. Finally, Maseco LLP purchased a new position in Veeva Systems during the 2nd quarter worth $35,000. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Price Performance
Shares of NYSE:VEEV opened at $293.67 on Wednesday. The firm has a market capitalization of $48.14 billion, a price-to-earnings ratio of 60.30, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. The business’s 50 day simple moving average is $285.50 and its 200-day simple moving average is $274.00. Veeva Systems Inc. has a 12 month low of $201.54 and a 12 month high of $310.50.
Insider Buying and Selling
In other Veeva Systems news, SVP Jonathan Faddis sold 720 shares of Veeva Systems stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $298.12, for a total transaction of $214,646.40. Following the completion of the transaction, the senior vice president owned 7,868 shares in the company, valued at approximately $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the company’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the sale, the insider directly owned 25,325 shares in the company, valued at $7,765,151.50. This trade represents a 19.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 24,665 shares of company stock worth $7,438,000 in the last three months. Corporate insiders own 10.30% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on VEEV shares. Wells Fargo & Company lifted their target price on shares of Veeva Systems from $300.00 to $326.00 and gave the company an “overweight” rating in a report on Tuesday, August 26th. Weiss Ratings restated a “hold (c+)” rating on shares of Veeva Systems in a research report on Wednesday, October 8th. KeyCorp boosted their target price on Veeva Systems from $285.00 to $325.00 and gave the stock an “overweight” rating in a research report on Monday, July 14th. Raymond James Financial reissued an “outperform” rating and issued a $340.00 price target (up from $310.00) on shares of Veeva Systems in a report on Thursday, August 28th. Finally, UBS Group lifted their price target on Veeva Systems from $285.00 to $310.00 and gave the company a “neutral” rating in a research note on Thursday, August 28th. Seventeen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $307.58.
View Our Latest Stock Report on VEEV
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- Using the MarketBeat Stock Split Calculator
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- Retail Stocks Investing, Explained
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- How to Use Stock Screeners to Find Stocks
- Uber Is Crushing Lyft—And It’s Not Even Close
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
